10-Q quarterly report · filed Nov 13, 2026

SBC Medical Group Holdings Inc (SBC) Q3 2026 10-Q Quarterly Report

Short answer

SBC Medical Group Holdings Inc (SBC) filed its Q3 2026 10-Q quarterly report on Nov 13, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $59M (up 35.1% year over year) with net income of $16M.

Q3 2026 key financials · XBRL

Revenue
$59M
+35.1% YoY · +19.1% QoQ
Net income
$16M
+22.4% YoY · +46.8% QoQ
Operating margin
45.1%
Gross margin
72.0%
EPS (diluted)
$0.16
+23.1% YoY · +60.0% QoQ

Source: XBRL data from the SBC Medical Group Holdings Inc (SBC) Q3 2026 10-Q on SEC EDGAR. USD.

SBC Medical Group Holdings Inc Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Quarterly revenue $58.6M, up 35.13% YoY from $43.4M
  • Operating margin 45.09% vs 36.63% YoY, net income margin 26.79% vs 29.58%
  • Best line management services revenue $16.4M, up 73.28%; weakest franchising revenue $9.6M, down 3.60%
  • Cash $198.4M vs $163.8M at December 31, 2025; operating cash flow $50.2M vs $(27.3)M
  • Capital deployment: $8.9M borrowing repayments, $5.0M investment commitment, no share repurchases under $20.0M authorization

Risk Factors

  • New Nasdaq compliance risk: independent director departure triggered board and audit committee violations on July 8, 2026
  • Most material update: delisting risk, Nasdaq cure period runs through July 9, 2027
  • Regulatory risk: delisting could reduce liquidity and classify common stock as a penny stock
  • Operational risk: failure to appoint independent directors could prevent restored Nasdaq compliance
  • Financial risk: delisting could decrease ability to issue securities or obtain future financing

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other SBC Medical Group Holdings Inc quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.